Detalhe da pesquisa
1.
Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lung.
Cell
; 185(1): 113-130.e15, 2022 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34921774
2.
mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron.
Cell
; 185(9): 1556-1571.e18, 2022 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35447072
3.
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies.
Cell
; 184(16): 4203-4219.e32, 2021 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34242577
4.
mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates.
Nat Immunol
; 22(10): 1306-1315, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34417590
5.
COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge.
Immunity
; 54(8): 1869-1882.e6, 2021 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34270939
6.
Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses.
Nature
; 594(7864): 553-559, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33971664
7.
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness.
Nature
; 586(7830): 567-571, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32756549
8.
Chitinase 3-like 1 is a profibrogenic factor overexpressed in the aging liver and in patients with liver cirrhosis.
Proc Natl Acad Sci U S A
; 118(17)2021 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33888584
9.
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.
N Engl J Med
; 383(16): 1544-1555, 2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32722908
10.
Fatal progression of experimental visceral leishmaniasis is associated with intestinal parasitism and secondary infection by commensal bacteria, and is delayed by antibiotic prophylaxis.
PLoS Pathog
; 16(4): e1008456, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32282850
11.
Distinct disease features in chimpanzees infected with a precore HBV mutant associated with acute liver failure in humans.
PLoS Pathog
; 16(8): e1008793, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32866189
12.
Role of humoral immunity against hepatitis B virus core antigen in the pathogenesis of acute liver failure.
Proc Natl Acad Sci U S A
; 115(48): E11369-E11378, 2018 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30420516
13.
Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody.
PLoS Pathog
; 13(8): e1006565, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28817732
14.
In Vitro Neutralization Is Not Predictive of Prophylactic Efficacy of Broadly Neutralizing Monoclonal Antibodies CR6261 and CR9114 against Lethal H2 Influenza Virus Challenge in Mice.
J Virol
; 91(24)2017 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29046448
15.
Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection.
J Infect Dis
; 213(10): 1557-61, 2016 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26941283
16.
Mycobacterium tuberculosis dysregulates MMP/TIMP balance to drive rapid cavitation and unrestrained bacterial proliferation.
J Pathol
; 235(3): 431-44, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25186281
17.
SARS-CoV-2 mucosal vaccine protects against clinical disease with sex bias in efficacy.
Vaccine
; 42(2): 339-351, 2024 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38071106
18.
Commercial influenza vaccines vary in HA-complex structure and in induction of cross-reactive HA antibodies.
Nat Commun
; 14(1): 1763, 2023 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36997521
19.
Corrigendum: Impact of adjuvant: trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus.
Front Immunol
; 14: 1283355, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37771593
20.
Durable immunity to SARS-CoV-2 in both lower and upper airways achieved with a gorilla adenovirus (GRAd) S-2P vaccine in non-human primates.
bioRxiv
; 2023 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38076895